Retraction
Activation of KRas-ERK1/2 signaling drives the initiation and progression of glioma by suppressing the acetylation of histone H4 at lysine 16
Paper Information
Record ID:
23617
Author(s):
Journal:
Publication Date:
April 01, 2019
Retraction Date:
June 18, 2020
(5.4 years years ago)
Subjects:
Institutions:
- Department of Neurosurgery, Jining No.1 People's Hospital, Jining 272011, China
- Affiliated Jining No.1 People's Hospital of Jining Medical University, Jining Medical University, Jining 272067, China
- Department of Pathology, Jining No.1 People's Hospital, Jining 272011, China
- Department of Neurosurgery, Affiliated Hospital of Jining Medical University, Jining 272000, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (5)
5
Total Citations1
Post-Retraction(20.0%)
2
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
1
After 2+ years
981
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Activation of KRas-ERK1/2 signaling drives the ini...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Activation of KRas-ERK1/2 signaling drives the ini...
Unknown Authors
Unknown Journal
Published: Feb 2023
981 days after retraction
Paper citing Activation of KRas-ERK1/2 signaling drives the ini...
Unknown Authors
Unknown Journal
Published: Feb 2020
122 days before retraction
Paper citing Activation of KRas-ERK1/2 signaling drives the ini...
Unknown Authors
Unknown Journal
Published: Sep 2019
286 days before retraction
Quick Stats
Total Citations:
5
Years Since Retraction:
5.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025